A Practical Approach to Management of Type 2 Diabetes Mellitus in 2020
Jeremy Gilbert, MD, FRCPC
Topics: Type 2 Diabetes
Details
Objectives
- Apply recent evidence on use of SGLT2 inhibitors in people with and without diabetes for use in heart failure and CKD.
- Discuss the optimal selection of antihyperglycemic agents based on individual case profiles.
- Review the practical considerations of using SGLT2 inhibitors and GLP 1 receptor agonists in combination or separately.
Faculty
Jeremy Gilbert MD, FRCPC
Program Director, Adult Endocrinology and Metabolism
Sunnybrook Health Sciences Centre
Dr. Gilbert is heavily involved in the management, advancement and continuing medical education of Diabetes. Jeremy completed his medical degree, internal medicine training and endocrinology residency at the University of Toronto. He is an associate professor at the University of Toronto. He is the program director for adult endocrinology and metabolism at the University of Toronto. He has authored a chapter in the 2013 and 2018 Diabetes Canada Guidelines and was a member of the steering committee of the 2018 Diabetes Canada Guidelines. He is on the executive and is a national editor for the Canadian Journal of Diabetes. He is a passionate teacher and his academic interest is in undergraduate, postgraduate and continuing medical education in diabetes and endocrinology. He has received numerous awards for outstanding teaching.